Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells

Resistance to currently available therapies is a major impediment to the successful treatment of hematological malignancies. Here, we used a model of therapy-resistant B-cell nonHodgkin lymphoma (B-NHL) developed in our laboratory along with primary B-NHL cells to study basic mechanisms of bortezomi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Olejniczak, Scott H., Blickwedehl, Jennifer, Belicha-Villanueva, Alan, Bangia, Naveen, Riaz, Wasif, Mavis, Cory, Clements, James L., Gibbs, John, Hernandez-Ilizaliturri, Francisco J., Czuczman, Myron S.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2010
Teme:
Lymphoid Neoplasia
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031407/
https://ncbi.nlm.nih.gov/pubmed/20930068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-12-259754
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items